Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Characterization of human platelet binding of recombinant T cell receptor ligand.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Low-contrast visual tests reveal better alemtuzumab efficacy
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
Anti-integrin therapy for multiple sclerosis.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Systematic approaches to central nervous system myelin.

Pages